Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.
Gansevoort
R T
RT
Wapstra
F H
FH
Weening
J J
JJ
de Jong
P E
PE
de Zeeuw
D
D
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D004039:Diet, Sodium-Restricted; D004195:Disease Models, Animal; D004317:Doxorubicin; D008297:Male; D009401:Nephrosis / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D011507:Proteinuria / Q000517:prevention & control*; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000494:pharmacology*
D000806:Angiotensin-Converting Enzyme Inhibitors; D004317:Doxorubicin; D012964:Sodium